NASDAQ:MGEN

Miragen Therapeutics SEC Filings & 10K Form

Notice: This company has been marked as potentially delisted and may not be actively trading.
$16.80
+0.10 (+0.60 %)
(As of 07/28/2021 12:00 AM ET)
Add
Compare
Today's Range
$16.52
$17.18
50-Day Range
$14.34
$23.01
52-Week Range
$4.66
$34.05
Volume2,824 shs
Average Volume134,027 shs
Market Capitalization$65.65 million
P/E RatioN/A
Dividend YieldN/A
Beta1.66

Miragen Therapeutics (NASDAQ:MGEN) SEC Filings

DateFilerForm TypeView
07/27/2021
4:02 PM
Humer Kristian (Reporting)
Miragen Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/27/2021
3:55 PM
Humer Kristian (Reporting)
Miragen Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
07/27/2021
3:13 PM
Humer Kristian (Reporting)
Miragen Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
07/26/2021
6:35 AM
Miragen Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/16/2021
5:34 PM
Kiselak Tomas (Reporting)
Miragen Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/16/2021
5:27 PM
Morris Arlene (Reporting)
Miragen Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/16/2021
5:26 PM
Harwin Peter Evan (Reporting)
Miragen Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/15/2021
4:30 PM
Miragen Therapeutics (Filer)
Form 8-K/A
06/04/2021
5:13 AM
Miragen Therapeutics (Filer)
Form DEFA14A
06/04/2021
5:08 AM
Miragen Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/01/2021
3:02 PM
D. E. SHAW & CO, L.P. (Filed by)
Miragen Therapeutics (Subject)
Form SC 13G/A
05/07/2021
5:04 AM
Miragen Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
04/30/2021
7:31 AM
Miragen Therapeutics (Filer)
Form DEF 14A
04/23/2021
4:30 PM
Miragen Therapeutics (Filer)
Form 424B3
04/23/2021
4:28 PM
Miragen Therapeutics (Filer)
Form 424B5
04/14/2021
3:16 PM
Miragen Therapeutics (Filer)
Form PRE 14A
03/25/2021
3:06 PM
Miragen Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/15/2021
3:38 PM
RA CAPITAL MANAGEMENT, L.P. (Filed by)
Miragen Therapeutics (Subject)
Form SC 13G/A
03/10/2021
6:17 AM
Miragen Therapeutics (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
Form SC 13G
02/19/2021
7:02 AM
Hawkes Bay Master Investors L.P. (0001645257) (Filed by)
Miragen Therapeutics (Subject)
Form SC 13G
02/16/2021
2:09 PM
Point72 Asset Management, L.P. (Filed by)
Miragen Therapeutics (Subject)
Form SC 13G/A
02/08/2021
4:41 PM
TURNER JOSEPH L (Reporting)
Miragen Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/08/2021
4:40 PM
Hatfield Jeffrey S. (Reporting)
Miragen Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/08/2021
4:40 PM
Harwin Peter Evan (Reporting)
Miragen Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/08/2021
4:40 PM
Kiselak Tomas (Reporting)
Miragen Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/08/2021
4:38 PM
Morris Arlene (Reporting)
Miragen Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/21/2021
6:45 PM
Katz Barrett (Reporting)
Miragen Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
01/21/2021
6:33 PM
Katz Barrett (Reporting)
Miragen Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/20/2021
2:55 PM
Leverone Jason A. (Reporting)
Miragen Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/20/2021
2:48 PM
Violin Jonathan (Reporting)
Miragen Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/20/2021
7:01 AM
Miragen Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/19/2021
7:11 PM
Escolar Diana (Reporting)
Miragen Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/19/2021
7:04 PM
Rauch Lee M. (Reporting)
Miragen Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/19/2021
3:18 PM
Cormorant Asset Management, LP (Filed by)
Miragen Therapeutics (Subject)
Form SC 13G
01/15/2021
6:47 PM
Marshall William Stuart (Reporting)
Miragen Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/11/2021
3:08 PM
CITADEL ADVISORS LLC (Filed by)
Miragen Therapeutics (Subject)
Form SC 13G
01/11/2021
11:07 AM
Miragen Therapeutics (Subject)
Xencor Inc (Filed by)
Form SC 13G
01/07/2021
6:36 AM
Ally Bridge MedAlpha Master Fund L.P. (Filed by)
Miragen Therapeutics (Subject)
Form SC 13G
01/05/2021
5:04 AM
Fairmount Funds Management LLC (Filed by)
Miragen Therapeutics (Subject)
Form SC 13D
01/04/2021
3:16 PM
Miragen Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/23/2020
4:05 PM
Miragen Therapeutics (Filer)
Form 424B5
12/22/2020
11:15 PM
Miragen Therapeutics (Filer)
Form EFFECT
12/17/2020
3:40 PM
Miragen Therapeutics (Subject)
RA CAPITAL MANAGEMENT, L.P. (Filed by)
Form SC 13G
12/17/2020
3:39 PM
Kolchinsky Peter (Reporting)
Miragen Therapeutics (Issuer)
RA Capital Healthcare Fund LP (Reporting)
RA CAPITAL MANAGEMENT, L.P. (Reporting)
Shah Rajeev M. (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
12/17/2020
6:07 AM
Miragen Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/11/2020
3:46 PM
Miragen Therapeutics (Filer)
Form 424B5
12/09/2020
8:03 AM
Miragen Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/08/2020
3:11 PM
Miragen Therapeutics (Filer)
Form PRER14A
12/04/2020
3:34 PM
Miragen Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/24/2020
7:26 AM
Miragen Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
11/20/2020
4:28 PM
COHEN STEVEN A/SAC CAPITAL MGMT LP (Reporting)
Miragen Therapeutics (Issuer)
Point72 Asset Management, L.P. (Reporting)
Point72 Capital Advisors, Inc. (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
11/20/2020
3:10 PM
Miragen Therapeutics (Filer)
Form PRE 14A
11/16/2020
5:23 PM
Logos Global Master Fund LP (Reporting)
Miragen Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/16/2020
5:19 PM
Logos Global Master Fund LP (Reporting)
Miragen Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
11/13/2020
3:15 PM
Miragen Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/12/2020
6:04 AM
Miragen Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/10/2020
3:18 PM
Miragen Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/10/2020
9:27 AM
FMR LLC (Filed by)
Miragen Therapeutics (Subject)
Form SC 13G/A
11/09/2020
4:26 PM
BIOTECHNOLOGY VALUE FUND L P (Filed by)
Miragen Therapeutics (Subject)
Form SC 13G
11/09/2020
11:26 AM
Logos Global Management LP (Filed by)
Miragen Therapeutics (Subject)
Form SC 13G
11/06/2020
3:23 PM
Miragen Therapeutics (Filer)
Form D
Notice of Exempt Offering of Securities 
10/30/2020
5:57 PM
Miragen Therapeutics (Issuer)
Violin Jonathan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/30/2020
5:45 PM
Miragen Therapeutics (Issuer)
Violin Jonathan (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
10/30/2020
10:53 AM
Fairmount Funds Management LLC (Reporting)
Fairmount Healthcare Fund GP LLC (Reporting)
Fairmount Healthcare Fund II GP LLC (Reporting)
Fairmount Healthcare Fund II L.P. (Reporting)
Fairmount Healthcare Fund L.P. (Reporting)
Miragen Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/30/2020
10:43 AM
Fairmount Funds Management LLC (Reporting)
Fairmount Healthcare Fund GP LLC (Reporting)
Fairmount Healthcare Fund II GP LLC (Reporting)
Fairmount Healthcare Fund II L.P. (Reporting)
Fairmount Healthcare Fund L.P. (Reporting)
Miragen Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
10/29/2020
4:19 PM
Harwin Peter Evan (Reporting)
Miragen Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/29/2020
4:16 PM
Kiselak Tomas (Reporting)
Miragen Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/29/2020
3:51 PM
Miragen Therapeutics (Subject)
Point72 Asset Management, L.P. (Filed by)
Form SC 13G
10/29/2020
10:30 AM
Fairmount Funds Management LLC (Reporting)
Fairmount Healthcare Fund GP LLC (Reporting)
Fairmount Healthcare Fund II GP LLC (Reporting)
Fairmount Healthcare Fund II L.P. (Reporting)
Fairmount Healthcare Fund L.P. (Reporting)
Miragen Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/28/2020
6:37 PM
Harwin Peter Evan (Reporting)
Miragen Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
10/28/2020
6:37 PM
Kiselak Tomas (Reporting)
Miragen Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
10/28/2020
8:28 AM
Miragen Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/14/2020
3:15 PM
Miragen Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/05/2020
3:09 PM
Miragen Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/01/2020
3:17 PM
Miragen Therapeutics (Filer)
Form 8-K/A
09/17/2020
4:31 PM
Miragen Therapeutics (Issuer)
Rauch Lee M. (Reporting)
Form 4/A
09/17/2020
4:24 PM
Miragen Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/15/2020
8:45 PM
Miragen Therapeutics (Issuer)
Rauch Lee M. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/25/2020
4:16 PM
Marshall William Stuart (Reporting)
Miragen Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/20/2020
3:07 PM
Miragen Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/05/2020
4:08 PM
Miragen Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
07/24/2020
5:07 AM
Miragen Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/25/2020
7:42 PM
Miragen Therapeutics (Issuer)
Rauch Lee M. (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
06/23/2020
8:17 AM
Miragen Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/22/2020
4:35 PM
Hatfield Jeffrey S. (Reporting)
Miragen Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/22/2020
4:21 PM
Miragen Therapeutics (Issuer)
TURNER JOSEPH L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/22/2020
4:18 PM
Miragen Therapeutics (Issuer)
Morris Arlene (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/22/2020
4:16 PM
KOCH KEVIN (Reporting)
Miragen Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/22/2020
4:13 PM
Hughes Thomas E. (Reporting)
Miragen Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/22/2020
4:09 PM
Bowden Christopher (Reporting)
Miragen Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/22/2020
3:15 PM
Miragen Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/14/2020
11:15 PM
Miragen Therapeutics (Filer)
Form EFFECT
04/10/2020
3:18 PM
Miragen Therapeutics (Filer)
Form DEFA14A
04/10/2020
3:17 PM
Miragen Therapeutics (Filer)
Form DEF 14A
03/27/2020
3:16 PM
Miragen Therapeutics (Filer)
Form PRE 14A
03/17/2020
3:22 PM
Leverone Jason A. (Reporting)
Miragen Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/13/2020
3:25 PM
Miragen Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
02/14/2020
5:24 PM
Escolar Diana (Reporting)
Miragen Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2020
5:21 PM
Leverone Jason A. (Reporting)
Miragen Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2020
5:18 PM
Marshall William Stuart (Reporting)
Miragen Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
This page was last updated on 7/28/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.